Next Article in Journal
A Split-Luciferase Reporter Recognizing GFP and mCherry Tags to Facilitate Studies of Protein–Protein Interactions
Next Article in Special Issue
The Origin of Skin Dendritic Cell Network and Its Role in Psoriasis
Previous Article in Journal
Differential Effects of sEH Inhibitors on the Proliferation and Migration of Vascular Smooth Muscle Cells
Previous Article in Special Issue
Adjuvant Biological Therapies in Chronic Leg Ulcers
Article Menu
Issue 12 (December) cover image

Export Article

Open AccessReview
Int. J. Mol. Sci. 2017, 18(12), 2684; https://doi.org/10.3390/ijms18122684

Molecular Mechanisms and Management of a Cutaneous Inflammatory Disorder: Psoriasis

1
Department of Dermatology, Yeouido St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul 07345, Korea
2
Department of Life Science, Sookmyung Women’s University, Seoul 04310, Korea
*
Author to whom correspondence should be addressed.
Received: 30 November 2017 / Revised: 7 December 2017 / Accepted: 7 December 2017 / Published: 11 December 2017
(This article belongs to the Special Issue Inflammatory Skin Conditions 2017)
Full-Text   |   PDF [1828 KB, uploaded 11 December 2017]   |  

Abstract

Psoriasis is a complex chronic inflammatory cutaneous disorder. To date, robust molecular mechanisms of psoriasis have been reported. Among diverse aberrant immunopathogenetic mechanisms, the current model emphasizes the role of Th1 and the IL-23/Th17 axis, skin-resident immune cells and major signal transduction pathways involved in psoriasis. The multiple genetic risk loci for psoriasis have been rapidly revealed with the advent of a novel technology. Moreover, identifying epigenetic modifications could bridge the gap between genetic and environmental risk factors in psoriasis. This review will provide a better understanding of the pathogenesis of psoriasis by unraveling the complicated interplay among immunological abnormalities, genetic risk foci, epigenetic modification and environmental factors of psoriasis. With advances in molecular biology, diverse new targets are under investigation to manage psoriasis. The recent advances in treatment modalities for psoriasis based on targeted molecules are also discussed. View Full-Text
Keywords: biologics; epigenetics; genetics; interleukin-23; psoriasis; signaling pathway; small molecules; T helper 17 cells biologics; epigenetics; genetics; interleukin-23; psoriasis; signaling pathway; small molecules; T helper 17 cells
Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).
SciFeed

Share & Cite This Article

MDPI and ACS Style

Woo, Y.R.; Cho, D.H.; Park, H.J. Molecular Mechanisms and Management of a Cutaneous Inflammatory Disorder: Psoriasis. Int. J. Mol. Sci. 2017, 18, 2684.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top